Literature DB >> 7513372

Expression of functional Fas antigen on adult T-cell leukemia.

T Kotani1, Y Aratake, S Kondo, K Tamura, S Ohtaki.   

Abstract

The expression of Fas antigen was analyzed in the peripheral blood mononuclear cells of 12 patients with adult T-cell leukemia (ATL) by flow cytometry. The induction of apoptosis in these cells by adding an anti-Fas antibody and the expression of activated T-cell surface antigens, CD25 and CD26, were also studied. It appears that the cells in ATL expressed a significantly larger number of Fas antigens than those in normal subjects (p < 0.01) and their fluorescent intensity was also shown to be much stronger in ATL (p < 0.01). The large number of ATL cells showed apoptosis in a short-term culture in the presence of the anti-Fas antibody. There was no difference in the expression of Fas antigen among ATL cells with different phenotypes of CD4+/CD8-, CD4-/CD8- and CD4+/CD8+ as well as with clinical subtypes of ATL. Interestingly, the expression of Fas and CD26 antigens showed a negative correlation (p < 0.01, r = 0.78). The strong expression of functional Fas antigen in ATL leads to the impression that anti-Fas antibody could be one of the treatment modalities for ATL which is known to be a very difficult disease to cope with.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513372     DOI: 10.1016/0145-2126(94)90034-5

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 2.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

3.  Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.

Authors:  Tomohiro Tsuji; Kazuyuki Sugahara; Kazuto Tsuruda; Akiko Uemura; Hitomi Harasawa; Hiroo Hasegawa; Yukio Hamaguchi; Masao Tomonaga; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

4.  Fas gene mutation in the progression of adult T cell leukemia.

Authors:  T Maeda; Y Yamada; R Moriuchi; K Sugahara; K Tsuruda; T Joh; S Atogami; K Tsukasaki; M Tomonaga; S Kamihira
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.